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Seroprevalence of Human Hantavirus
Infection in the Ribeirão Preto Region
of São Paulo State, Brazil
To the Editor: Hantavirus pulmonary syndrome
(HPS) has been identified in the region of
Ribeirão Preto, São Paulo State, Brazil, since
1993 (1-4). As of September 1999, 38 HPS cases
had been reported in Brazil, 16 in the state of
São Paulo (2). Between May 1998 and August
1999, the Adolfo Lutz Institute (ALI) in São
Paulo city serologically confirmed five cases—
three fatal—in the Ribeirão Preto region: two
from Guariba, one from Jardinópolis, one from
Cajuru, and one from Cassia dos Coqueiros
(Luiza Teresinha Madia de Souza, ALI, pers.
comm.).
Despite these reports and suspicions of
additional cases, the prevalence of hantavirus
infection and HPS in the region is not known.
Laboratory confirmation has not been available
locally, and sending serum samples to ALI for
laboratory evaluation is not feasible in most
cases. Thus, only presumptive diagnoses could
be made until the Sin Nombre virus (SNV)
enzyme-linked immunosorbent assay (ELISA)
was developed.
To estimate the occurrence and distribution
of human hantavirus infection, we used SNV
ELISA to conduct a serologic survey of a sample
of hospital patients requiring venipuncture for
routine procedures. The patients came from
three regional cities: Ribeirão Preto, Guariba,
and Jardinópolis. Between February and June
1999, a total of 567 samples were collected: 257
from the public hospital of Guariba, 110 from
the public hospital in Jardinópolis, and 200
from the General Hospital of the School of
Medicine of Ribeirão Preto. When we compared
our sample with the general population, the
patients in the study sample were slightly older
but similar in sex distribution.
Sixteen additional samples were evaluated
to confirm the effectiveness of SNV ELISA in
diagnosing hantavirus infection: 12 from patients
in whom HPS was clinically suspected and 4
previously confirmed by ALI in the city of São
Paulo between May 1998 and August 1999.
Known HPS convalescent-phase plasma provided
by the Centers for Disease Control and Preven-
tion (CDC) was used as positive control. Nega-
tive controls were selected by simple random
sampling from all previously negative samples.
Positive and negative recombinant SNV
antigens provided by CDC were coated on
microtiter plates at 1:2,000 dilution in phos-
phate-buffered saline overnight at 4°C and used
in a standard immunoglobulin G testing format.
Reverse transcriptase-polymerase chain reac-
tion analysis of serum from two fatal cases of
HPS occurring in the cities of Franca and
Araraquara suggested the presence of two
genetically distinct hantaviruses in the area
surrounding Ribeirão Preto. Antigen prepared
from local virus is not considered to be neces-
sary for immunoassays because the local virus
is not sufficiently different from other isolates
to require special antigen preparation (5).
All samples were screened in duplicate on
both positive and negative antigens in the
assay. A sample was considered positive if
absorbance on the positive antigen was greater
than absorbance on both the negative control
antigen and the negative control of the plate.
To confirm the diagnosis, samples satisfying
these criteria were tested in duplicate along
with 14 negative samples. Samples were
considered positive when their subtractive
absorbance was greater than the calculated
mean subtractive absorbance of the 14 negative
samples and three standard deviations.
From our serologic survey, the
seroprevalence of human hantavirus infection
was determined to be 1.23% (7/567) overall,
0.5% (1/200) in Ribeirão Preto, 0.4% (1/257) in
Guariba, and 4.5% (5/110) in Jardinópolis. If
one assumes the inhabitants sampled were
representative, the seroprevalence provides an
estimate of surviving past or recent hantavirus
infections in the area. As the overall antibody
prevalence of 1.23% is more than twice that
observed in the U.S. populations at risk for
hantavirus infection, such infections are not
rare in the Ribeirão Preto region (6).Vol. 6, No. 5, September–October 2000 Emerging Infectious Diseases 561
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Three of the four HPS samples previously
confirmed by the ALI in São Paulo tested
positive by our ELISA. Of the remaining 12
suspected HPS cases assayed, three were
positive. Two of these three were later con-
firmed as positive by the ALI (Luiza Teresinha
Madia de Souza, ALI, pers. comm.) Thus, we
report three previously unconfirmed HPS cases,
one fatal, in the Ribeirão Preto area between
May 1998 and August 1999.
Since the rodent reservoir is not known and
the virus has not been isolated, rodent capture
is currently being conducted in areas where
human infections have been found. In addition,
positive cases are being retrospectively investi-
gated.
Thanks to Thomas Ksiazek for providing recombinant
SNV antigen and positive serum and to Robert Shope for
his assistance.
The study was partially funded by grants from the
National Institutes of Health, Bethesda, Maryland, USA,
and Fundação de Amparo à Pesquisa do Estado de São
Paulo, Brazil.
Ryan Holmes,* Rodrigo Boccanera,†
Luiz Tadeu M. Figueiredo,†
Silvia Regina Mançano,‡ Clodoaldo Pane§
*University of Texas Medical Branch at Galveston,
University of Texas School of Public Health at
Houston, Texas, USA; †Unidade Multidepartamental
de Pesquisa em Virologia da Faculdade de Medicina
de Ribeirão Preto-USP, Brazil; ‡Centro de Saúde de
Guariba, São Paulo State, Brazil; and §Centro de
Saúde de Jardinópolis, São Paulo State, Brazil.
References
  1. Figueiredo LTM, Moreli ML, Almeida VSO, Félix PR,
Bruno, JC, Ferreira IB, et al. Hantavirus pulmonary
syndrome (HPS) in Guariba, SP, Brazil. A report of 2
cases. Rev Inst Med Trop Sao Paulo 1999; 41:131-7.
  2. Johnson AM, de Souza LTM, Ferreira IB, Pereira LE,
Ksiazek TG, Rollin PE, et al. Genetic investigation of
novel hantaviruses causing fatal HPS in Brazil. J
Med Virol 1999;59:527-35.
  3. Ferreira MS, Nishioka SA, Santos TL, Santos RP,
Santos PS, Rocha A. Hantavirus pulmonary
syndrome in Brazil: clinical aspects of three new
cases. Rev Inst Med Trop Sao Paulo 2000;42:41-6.
  4. Da Silva MV, Vasconcelos MJ, Hidalgo NT, Veiga AP,
Canzian M, Marotto PC, et al. Hantavirus pulmonary
syndrome: report of the first three cases in São Paulo,
Brazil. Rev Inst Med Trop Sao Paulo 1997;39:231-4.
  5. Peters CJ. Emerging infections: hantavirus
pulmonary syndrome in the Americas. Washington:
ASM Press;1998.
  6. Zeitz PS, Butler JC, Cheek JE, Samuel MC, Childs
JE, Shands LA, et al. A case-control study of
hantavirus pulmonary syndrome during an outbreak
in the southwestern United States. J Infect Dis
1995;171:864-70.
Molecular Characterization of
Mycobacterium abscessus Strains
Isolated from a Hospital Outbreak
To the Editor: In recent years there have been
several reports of sporadic and epidemic hospital-
acquired infections caused by rapidly growing
mycobacteria, namely, Mycobacterium absces-
sus, M. chelonae, and M. fortuitum.
M. abscessus has been well documented as a
cause of cutaneous and soft tissue infections
and has been implicated in chronic ear infec-
tions, bacteremia associated with hemodialysis
equipment, and peritoneal dialysis–related
infections (1).
Differentiating mycobacteria to the species
level is difficult because of the diversity of
available techniques and the time required for
full identification. A rapid method based on the
evaluation of the gene coding for the 65-kDa
heat shock protein, which contains epitopes
both unique and common to various species of
mycobacteria, has been reported (2). A 383-bp
sequence situated at the amino terminus of this
65-kDa antigen (3) has been shown to be
conserved among several species of mycobacte-
ria. Reports based on polymerase chain reaction
(PCR) amplification and DNA sequencing (4)
show species-specific polymorphism at the
nucleotide level within this region (5). The
conserved nature of this gene allows differentia-
tion of mycobacteria within 1 day by restriction
enzyme digestion of PCR products obtained by
using primers common to all mycobacteria.
From August through December 1995,
postoperative wound infections developed in
45 patients in the pediatric surgery unit of
Kalawati Saran Children’s Hospital, New Delhi,
India; 42 were day-care patients, and 3 were
inpatients who had undergone major surgery.
Thirty-two clinical samples (pus and exudate)
were tested for acid-fast bacilli by the Ziehl-
Neelson method; the same smear samples were
cultured on Lowenstein-Jensen slants and
examined for growth daily for 4 days and
thereafter twice a week for 8 weeks. The